查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1622868

喷雾器设备的全球市场:产业分析，规模，占有率，成长，趋势，预测(2024年～2031年)

Nebulizer Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 244 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2024年全球雾化器市场规模将达到11.208亿美元，2024-2031年预测期间复合年增长率为8.5%，2031年将达到19.78亿美元。

雾化器用于以雾状形式将药物吸入肺部，主要用于治疗气喘、慢性阻塞性肺病（COPD）和囊性纤维化等呼吸系统疾病。雾化器包括喷射雾化器、网状雾化器和超音波雾化器，用于家庭保健和医院环境。市场成长的主要驱动力包括呼吸系统疾病盛行率的增加、老年人口的增加以及对呼吸系统健康意识的增强。

由于多种因素，包括全球气喘和慢性阻塞性肺病盛行率的上升，全球雾化器设备市场正在显着成长。人口老化加剧，更容易患呼吸道疾病，进一步推动了对雾化器设备的需求。此外，便携式和用户友好型设备等雾化器技术的进步以及医疗保健意识的提高正在促进市场成长。向家庭医疗保健解决方案的转变以及对非侵入性治疗的日益偏好也推动了雾化器在家庭环境中的采用。

由于人们对呼吸健康的认识不断增强以及对家庭护理解决方案的需求不断增长，雾化器设备市场正在提供巨大的机会。小型便携式电池供电雾化器的开发等创新提供了新的成长机会。由于环境因素和生活方式的改变，呼吸系统疾病呈上升趋势的新兴市场也存在巨大潜力。此外，扩大采用治疗气喘和慢性阻塞性肺病的联合疗法，为雾化器製造商提供了开发适合特定治疗的设备的机会。

本报告提供全球喷雾器设备市场相关调查，提供各产品类型，各终端用户，各用途，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场简介

第3章 市场观点

  • 宏观因素
  • 促进因素
  • 阻碍因素
  • 趋势
  • 机会
  • 国家展望（北美）
  • 国家展望（欧洲和亚太地区）
  • 美国慢性阻塞性肺病 (COPD) 盛行率
  • 美国气喘盛行率
  • 偏好和见解
  • 产品市场场景
  • 产品类型的演变
  • 利润率与利润分析
  • 製造商
  • 用于治疗气喘和慢性阻塞性肺病的药物
  • 救赎（北美洲）
  • 租赁产品场景（北美）
  • 保险（北美）
  • 波特五力分析
  • 主要规定

第4章 北美的喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)

  • 市场规模(100万美元)的分析，2019年～2023年，各国
  • 市场规模(100万美元)的预测，2024年～2031年，各国
  • 市场规模(100万美元)的分析，2019年～2023年，各产品类型
  • 市场规模(100万美元)的预测，2024年～2031年，各产品类型
  • 市场规模(100万美元)的分析，2019年～2023年，各用途
  • 市场规模(100万美元)的预测，2024年～2031年，各用途
  • 市场规模(100万美元)的分析，2019年～2023年，各终端用户
  • 市场规模(100万美元)的预测，2024年～2031年，各终端用户
  • 市场魅力分析
  • 主要的代表性的市场参与企业
  • 主要加入企业的市场影响(强度地图)

第5章 南美的喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)

第6章 西欧的喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)

第7章 东欧的喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)

第8章 日本以外亚太地区的喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)

第9章 日本的喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)

第10章 中东·非洲的喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)

第11章 预测要素:相关性及影响

第12章 预测的前提条件

第13章 竞争情形

  • 竞争仪表板
  • 企业简介(详细内容- 概要，财务，策略，最近的趋势)
    • Agilent Technologies, Inc.
    • Allied Healthcare Products, Inc.
    • CareFusion Corporation (sub. Becton, Dickinson and Company)
    • Covidien plc (sub. Medtronic)
    • GE Healthcare
    • GF Health Products Inc.
    • Omron Healthcare, Inc.
    • PARI GmbH
    • Koninklijke Philips N.V.

第14章 全球喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)，各地区

  • 市场规模(100万美元)的分析，2019年～2023年，各地区
  • 市场规模(100万美元)的预测，2024年～2031年，各地区
  • 市场魅力分析，各地区

第15章 全球喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)，各产品类型

  • 市场规模(100万美元)的分析，2019年～2023年，各产品类型
  • 市场规模(100万美元)的预测，2024年～2031年，各产品类型
  • 市场魅力分析，各产品类型

第16章 全球喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)，各用途

  • 市场规模(100万美元)的分析，2019年～2023年，各用途
  • 市场规模(100万美元)的预测，2024年～2031年，各用途
  • 市场魅力分析，各用途

第17章 喷雾器设备市场分析(2019年～2023年)及预测(2024年～2031年)，各终端用户

  • 市场规模(100万美元)的分析，2019年～2023年，各终端用户
  • 市场规模(100万美元)的预测，2024年～2031年，各终端用户
  • 市场魅力分析，各终端用户

第18章 全球(2019年～2023年)及预测(2024年～2031年)

第19章 调查手法

简介目录
Product Code: PMRREP22411

Persistence Market Research recently unveiled an in-depth report on the global Nebulizer Devices Market, analyzing key market dynamics, including drivers, trends, opportunities, and challenges. This comprehensive research provides exclusive data and projections for the nebulizer devices market's growth trajectory from 2024 to 2031.

Key Insights:

  • Nebulizer Devices Market Size (2024E): US$ 1120.8 Million
  • Projected Market Value (2031F): US$ 1978 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 8.5%

Nebulizer Devices Market Overview:

Nebulizers are medical devices used to administer medication in the form of a mist inhaled into the lungs, primarily for the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizer devices include jet nebulizers, mesh nebulizers, and ultrasonic nebulizers, with applications across both homecare and hospital settings. Key drivers of market growth include the increasing prevalence of respiratory diseases, the rising geriatric population, and the growing awareness about respiratory health.

Market Growth Drivers:

The global nebulizer devices market is experiencing significant growth due to several factors, including the rising incidence of asthma and COPD worldwide. The growing aging population, which is more susceptible to respiratory disorders, further fuels the demand for nebulizer devices. Additionally, advancements in nebulizer technology, such as portable and user-friendly devices, along with increasing healthcare awareness, are contributing to the growth of the market. The shift towards home healthcare solutions and the rising preference for non-invasive treatments also support the adoption of nebulizers in home settings.

Market Restraints:

Despite positive growth prospects, the nebulizer devices market faces certain challenges. One of the key barriers is the relatively high cost of nebulizers, which may limit their affordability, particularly in developing countries. Moreover, the lack of awareness in some regions about the benefits of nebulizer treatments can also hinder market adoption. Regulatory challenges, including lengthy approval processes for new devices and the need for consistent product standards, may slow down the introduction of new, innovative devices. Additionally, the maintenance and cleaning requirements of nebulizers could be a deterrent for some patients, especially in homecare settings.

Market Opportunities:

The nebulizer devices market offers significant opportunities driven by the rising awareness of respiratory health and the growing demand for homecare solutions. Technological innovations, such as the development of compact, portable, and battery-operated nebulizers, present new growth opportunities. There is also considerable potential in emerging markets, where respiratory diseases are on the rise due to environmental factors and lifestyle changes. Furthermore, the increasing adoption of combination therapies for asthma and COPD provides opportunities for nebulizer manufacturers to develop devices tailored to specific treatments.

Key Questions Addressed:

  • What are the main factors driving the global growth of the nebulizer devices market?
  • Which product types and applications are witnessing the highest adoption in the nebulizer devices market?
  • How are technological advancements shaping the competitive landscape of the nebulizer devices market?
  • Who are the leading players in the nebulizer devices market, and what strategies are they employing to maintain leadership?
  • What are the emerging trends and future prospects for the global nebulizer devices market?

Competitive Intelligence & Strategic Insights:

Major players in the global nebulizer devices market, including Philips Healthcare, Omron Healthcare, and PARI GmbH, focus on product innovation, strategic partnerships, and expanding their product portfolios to strengthen their market position. These companies invest in research and development to create more efficient, user-friendly nebulizer devices with enhanced features. Collaborations with healthcare providers, pharmaceutical companies, and homecare organizations are key strategies to expand market reach. Furthermore, raising consumer awareness through educational campaigns about the benefits of nebulizer therapy is crucial for improving market penetration and driving long-term growth.

Key Companies Profiled:

  • Agilent Technologies, Inc.
  • Allied Healthcare Products, Inc.
  • CareFusion Corporation (sub. Becton, Dickinson and Company)
  • Covidien plc (sub. Medtronic)
  • GE Healthcare
  • GF Health Products Inc.
  • Omron Healthcare, Inc.
  • PARI GmbH
  • Koninklijke Philips N.V.

Nebulizer Devices Market: Segmentation

By Product Type

  • Compressed Jet Nebulizer
  • Breath Actuated Pneumatic Nebulizer
  • Vented Actuated Pneumatic Nebulizer
  • Ultrasound Nebulizer
  • Mesh Nebulizer

By End User

Homecare Settings

  • Out Patient Settings
  • Others
  • Hospitals
  • Clinics
  • Long Term Centers

By Application

  • COPD
  • Cystic Fibrosis
  • Asthma

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Nebulizer Devices Market Overview

3. Market View Point

  • 3.1. Macro factors
  • 3.2. Drivers
  • 3.3. Restraints
  • 3.4. Trends
  • 3.5. Opportunities
  • 3.6. Outlook by Country (North America)
  • 3.7. Outlook by Country (Europe & Asia-Pacific)
  • 3.8. COPD Prevalence in U.S
  • 3.9. Asthma Prevalence in U.S
  • 3.10. Preferences and Insights
  • 3.11. Product Market Scenario
  • 3.12. Product Type Evolution
  • 3.13. Profit Margin and Revenue Analysis
  • 3.14. Manufacturer
  • 3.15. Drug Used for Asthma & COPD
  • 3.16. Reimbursement (North America)
  • 3.17. Rental Product Scenarios (North America)
  • 3.18. Insurances (North America)
  • 3.19. Porter's Five Forces Analysis
  • 3.20. Key Regulation

4. North America Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 4.4.1. Compressed Jet Nebulizer
      • 4.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 4.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 4.4.2. Ultrasound Nebulizer
    • 4.4.3. Mesh Nebulizer
  • 4.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 4.5.1. Compressed Jet Nebulizer
      • 4.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 4.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 4.5.2. Ultrasound Nebulizer
    • 4.5.3. Mesh Nebulizer
  • 4.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 4.6.1. COPD
    • 4.6.2. Cystic Fibrosis
    • 4.6.3. Asthma
    • 4.6.4. Others
  • 4.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 4.7.1. COPD
    • 4.7.2. Cystic Fibrosis
    • 4.7.3. Asthma
    • 4.7.4. Others
  • 4.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 4.8.1. Homecare Setting
    • 4.8.2. Out Patient Settings
    • 4.8.3. Others
      • 4.8.3.1. Hospitals
      • 4.8.3.2. Clinics
      • 4.8.3.3. Long Term Centers
  • 4.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 4.9.1. Homecare Setting
    • 4.9.2. Out Patient Settings
    • 4.9.3. Others
      • 4.9.3.1. Hospitals
      • 4.9.3.2. Clinics
      • 4.9.3.3. Long Term Centers
  • 4.10. Market Attractiveness Analysis
    • 4.10.1. By Country
    • 4.10.2. By Product Type
    • 4.10.3. By Application
    • 4.10.4. By End User
  • 4.11. Key Representative Market Participants
  • 4.12. Key Participants Market Presence (Intensity Map)

5. Latin America Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 5.4.1. Compressed Jet Nebulizer
      • 5.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 5.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 5.4.2. Ultrasound Nebulizer
    • 5.4.3. Mesh Nebulizer
  • 5.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 5.5.1. Compressed Jet Nebulizer
      • 5.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 5.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 5.5.2. Ultrasound Nebulizer
    • 5.5.3. Mesh Nebulizer
  • 5.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 5.6.1. COPD
    • 5.6.2. Cystic Fibrosis
    • 5.6.3. Asthma
    • 5.6.4. Others
  • 5.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 5.7.1. COPD
    • 5.7.2. Cystic Fibrosis
    • 5.7.3. Asthma
    • 5.7.4. Others
  • 5.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 5.8.1. Homecare Setting
    • 5.8.2. Out Patient Settings
    • 5.8.3. Others
      • 5.8.3.1. Hospitals
      • 5.8.3.2. Clinics
      • 5.8.3.3. Long Term Centers
  • 5.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 5.9.1. Homecare Setting
    • 5.9.2. Out Patient Settings
    • 5.9.3. Others
      • 5.9.3.1. Hospitals
      • 5.9.3.2. Clinics
      • 5.9.3.3. Long Term Centers
  • 5.10. Market Attractiveness Analysis
    • 5.10.1. By Country
    • 5.10.2. By Product Type
    • 5.10.3. By Application
    • 5.10.4. By End User
  • 5.11. Key Representative Market Participants
  • 5.12. Key Participants Market Presence (Intensity Map)

6. Western Europe Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 6.2.1. Germany
    • 6.2.2. U.K
    • 6.2.3. France
    • 6.2.4. Spain
    • 6.2.5. Italy
    • 6.2.6. Nordic Countries
    • 6.2.7. Rest of Western Europe
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 6.3.1. Germany
    • 6.3.2. U.K
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Nordic Countries
    • 6.3.7. Rest of Western Europe
  • 6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 6.4.1. Compressed Jet Nebulizer
      • 6.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 6.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 6.4.2. Ultrasound Nebulizer
    • 6.4.3. Mesh Nebulizer
  • 6.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 6.5.1. Compressed Jet Nebulizer
      • 6.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 6.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 6.5.2. Ultrasound Nebulizer
    • 6.5.3. Mesh Nebulizer
  • 6.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 6.6.1. COPD
    • 6.6.2. Cystic Fibrosis
    • 6.6.3. Asthma
    • 6.6.4. Others
  • 6.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 6.7.1. COPD
    • 6.7.2. Cystic Fibrosis
    • 6.7.3. Asthma
    • 6.7.4. Others
  • 6.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 6.8.1. Homecare Setting
    • 6.8.2. Out Patient Settings
    • 6.8.3. Others
      • 6.8.3.1. Hospitals
      • 6.8.3.2. Clinics
      • 6.8.3.3. Long Term Centers
  • 6.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 6.9.1. Homecare Setting
    • 6.9.2. Out Patient Settings
    • 6.9.3. Others
      • 6.9.3.1. Hospitals
      • 6.9.3.2. Clinics
      • 6.9.3.3. Long Term Centers
  • 6.10. Market Attractiveness Analysis
    • 6.10.1. By Country
    • 6.10.2. By Product Type
    • 6.10.3. By Application
    • 6.10.4. By End User
  • 6.11. Key Representative Market Participants
  • 6.12. Key Participants Market Presence (Intensity Map)

7. Eastern Europe Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 7.2.1. Russia
    • 7.2.2. Poland
    • 7.2.3. Rest of Eastern Europe
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 7.3.1. Russia
    • 7.3.2. Poland
    • 7.3.3. Rest of Eastern Europe
  • 7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 7.4.1. Compressed Jet Nebulizer
      • 7.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 7.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 7.4.2. Ultrasound Nebulizer
    • 7.4.3. Mesh Nebulizer
  • 7.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 7.5.1. Compressed Jet Nebulizer
      • 7.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 7.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 7.5.2. Ultrasound Nebulizer
    • 7.5.3. Mesh Nebulizer
  • 7.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 7.6.1. COPD
    • 7.6.2. Cystic Fibrosis
    • 7.6.3. Asthma
    • 7.6.4. Others
  • 7.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 7.7.1. COPD
    • 7.7.2. Cystic Fibrosis
    • 7.7.3. Asthma
    • 7.7.4. Others
  • 7.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 7.8.1. Homecare Setting
    • 7.8.2. Out Patient Settings
    • 7.8.3. Others
      • 7.8.3.1. Hospitals
      • 7.8.3.2. Clinics
      • 7.8.3.3. Long Term Centers
  • 7.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 7.9.1. Homecare Setting
    • 7.9.2. Out Patient Settings
    • 7.9.3. Others
      • 7.9.3.1. Hospitals
      • 7.9.3.2. Clinics
      • 7.9.3.3. Long Term Centers
  • 7.10. Market Attractiveness Analysis
    • 7.10.1. By Country
    • 7.10.2. By Product Type
    • 7.10.3. By Application
    • 7.10.4. By End User
  • 7.11. Key Representative Market Participants
  • 7.12. Key Participants Market Presence (Intensity Map)

8. APEJ Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Australia & NZ
    • 8.2.4. ASEAN
    • 8.2.5. Rest of APEJ
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 8.3.1. China
    • 8.3.2. India
    • 8.3.3. Australia & NZ
    • 8.3.4. ASEAN
    • 8.3.5. Rest of APEJ
  • 8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 8.4.1. Compressed Jet Nebulizer
      • 8.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 8.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 8.4.2. Ultrasound Nebulizer
    • 8.4.3. Mesh Nebulizer
  • 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 8.5.1. Compressed Jet Nebulizer
      • 8.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 8.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 8.5.2. Ultrasound Nebulizer
    • 8.5.3. Mesh Nebulizer
  • 8.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 8.6.1. COPD
    • 8.6.2. Cystic Fibrosis
    • 8.6.3. Asthma
    • 8.6.4. Others
  • 8.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 8.7.1. COPD
    • 8.7.2. Cystic Fibrosis
    • 8.7.3. Asthma
    • 8.7.4. Others
  • 8.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 8.8.1. Homecare Setting
    • 8.8.2. Out Patient Settings
    • 8.8.3. Others
      • 8.8.3.1. Hospitals
      • 8.8.3.2. Clinics
      • 8.8.3.3. Long Term Centers
  • 8.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 8.9.1. Homecare Setting
    • 8.9.2. Out Patient Settings
    • 8.9.3. Others
      • 8.9.3.1. Hospitals
      • 8.9.3.2. Clinics
      • 8.9.3.3. Long Term Centers
  • 8.10. Market Attractiveness Analysis
    • 8.10.1. By Country
    • 8.10.2. By Product Type
    • 8.10.3. By Application
    • 8.10.4. By End User
  • 8.11. Key Representative Market Participants
  • 8.12. Key Participants Market Presence (Intensity Map)

9. Japan Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 9.2.1. Compressed Jet Nebulizer
      • 9.2.1.1. Breath Actuated Pneumatic Nebulizer
      • 9.2.1.2. Vented Actuated Pneumatic Nebulizer
    • 9.2.2. Ultrasound Nebulizer
    • 9.2.3. Mesh Nebulizer
  • 9.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 9.3.1. Compressed Jet Nebulizer
      • 9.3.1.1. Breath Actuated Pneumatic Nebulizer
      • 9.3.1.2. Vented Actuated Pneumatic Nebulizer
    • 9.3.2. Ultrasound Nebulizer
    • 9.3.3. Mesh Nebulizer
  • 9.4. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 9.4.1. COPD
    • 9.4.2. Cystic Fibrosis
    • 9.4.3. Asthma
    • 9.4.4. Others
  • 9.5. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 9.5.1. COPD
    • 9.5.2. Cystic Fibrosis
    • 9.5.3. Asthma
    • 9.5.4. Others
  • 9.6. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 9.6.1. Homecare Setting
    • 9.6.2. Out Patient Settings
    • 9.6.3. Others
      • 9.6.3.1. Hospitals
      • 9.6.3.2. Clinics
      • 9.6.3.3. Long Term Centers
  • 9.7. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 9.7.1. Homecare Setting
    • 9.7.2. Out Patient Settings
    • 9.7.3. Others
      • 9.7.3.1. Hospitals
      • 9.7.3.2. Clinics
      • 9.7.3.3. Long Term Centers
  • 9.8. Market Attractiveness Analysis
    • 9.8.1. By Product Type
    • 9.8.2. By Application
    • 9.8.3. By End User
  • 9.9. Key Representative Market Participants
  • 9.10. Key Participants Market Presence (Intensity Map)

10. MEA Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 10.1.Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 10.2.1. GCC Countries
    • 10.2.2. South Africa
    • 10.2.3. Rest of MEA
  • 10.3. Market Size (US$ Mn) Forecast By Country, , 2024 - 2031
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Rest of MEA
  • 10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 10.4.1. Compressed Jet Nebulizer
      • 10.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 10.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 10.4.2. Ultrasound Nebulizer
    • 10.4.3. Mesh Nebulizer
  • 10.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 10.5.1. Compressed Jet Nebulizer
      • 10.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 10.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 10.5.2. Ultrasound Nebulizer
    • 10.5.3. Mesh Nebulizer
  • 10.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 10.6.1. COPD
    • 10.6.2. Cystic Fibrosis
    • 10.6.3. Asthma
    • 10.6.4. Others
  • 10.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 10.7.1. COPD
    • 10.7.2. Cystic Fibrosis
    • 10.7.3. Asthma
    • 10.7.4. Others
  • 10.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 10.8.1. Homecare Setting
    • 10.8.2. Out Patient Settings
    • 10.8.3. Others
      • 10.8.3.1. Hospitals
      • 10.8.3.2. Clinics
      • 10.8.3.3. Long Term Centers
  • 10.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 10.9.1. Homecare Setting
    • 10.9.2. Out Patient Settings
    • 10.9.3. Others
      • 10.9.3.1. Hospitals
      • 10.9.3.2. Clinics
      • 10.9.3.3. Long Term Centers
  • 10.10. Market Attractiveness Analysis
    • 10.10.1. By Country
    • 10.10.2. By Product Type
    • 10.10.3. By Application
    • 10.10.4. By End User
  • 10.11. Key Representative Market Participants
  • 10.12. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.2.1. Agilent Technologies, Inc.
    • 13.2.2. Allied Healthcare Products, Inc.
    • 13.2.3. CareFusion Corporation (sub. Becton, Dickinson and Company)
    • 13.2.4. Covidien plc (sub. Medtronic)
    • 13.2.5. GE Healthcare
    • 13.2.6. GF Health Products Inc.
    • 13.2.7. Omron Healthcare, Inc.
    • 13.2.8. PARI GmbH
    • 13.2.9. Koninklijke Philips N.V.

14. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Region, 2019 - 2023
    • 14.2.1. North America
    • 14.2.2. Latin America
    • 14.2.3. Western Europe
    • 14.2.4. Eastern Europe
    • 14.2.5. APEJ
    • 14.2.6. Japan
    • 14.2.7. MEA
  • 14.3. Market Size (US$ Mn) Forecast By Region, 2024 - 2031
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Western Europe
    • 14.3.4. Eastern Europe
    • 14.3.5. APEJ
    • 14.3.6. Japan
    • 14.3.7. MEA
  • 14.4. Market Attractiveness Analysis By Region

15. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 15.2.1. Compressed Jet Nebulizer
      • 15.2.1.1. Breath Actuated Pneumatic Nebulizer
      • 15.2.1.2. Vented Actuated Pneumatic Nebulizer
    • 15.2.2. Ultrasound Nebulizer
    • 15.2.3. Mesh Nebulizer
  • 15.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 15.3.1. Compressed Jet Nebulizer
      • 15.3.1.1. Breath Actuated Pneumatic Nebulizer
      • 15.3.1.2. Vented Actuated Pneumatic Nebulizer
    • 15.3.2. Ultrasound Nebulizer
    • 15.3.3. Mesh Nebulizer
  • 15.4. Market Attractiveness Analysis By Product Type

16. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 16.2.1. COPD
    • 16.2.2. Cystic Fibrosis
    • 16.2.3. Asthma
    • 16.2.4. Others
  • 16.3. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 16.3.1. COPD
    • 16.3.2. Cystic Fibrosis
    • 16.3.3. Asthma
    • 16.3.4. Others
  • 16.4. Market Attractiveness Analysis By Application

17. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 17.2.1. Homecare Setting
    • 17.2.2. Out Patient Settings
    • 17.2.3. Others
      • 17.2.3.1. Hospitals
      • 17.2.3.2. Clinics
      • 17.2.3.3. Long Term Centers
  • 17.3. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 17.3.1. Homecare Setting
    • 17.3.2. Out Patient Settings
    • 17.3.3. Others
      • 17.3.3.1. Hospitals
      • 17.3.3.2. Clinics
    • 17.3.4. Long Term Centers
  • 17.4. Market Attractiveness Analysis By End User

18. Global Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 18.1.Market Size and Y-o-Y Growth
  • 18.2. Absolute $ Opportunity

19. Research Methodology